loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Tilmicosin Phosphate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Tilmicosin Phosphate

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: 137330-13-3, Tilmicosin (phosphate), Tilmicosin phosphate [usan], Ly177370 phosphate, Micotil 300, Smh7u1s683
    Molecular Formula
    C46H83N2O17P
    Molecular Weight
    967.1  g/mol
    InChI Key
    NESIVXZOSKKUDP-ARVJLQODSA-N
    FDA UNII
    SMH7U1S683
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-7-[2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]ethyl]-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione;phosphoric acid
    2.1.2 InChI
    InChI=1S/C46H80N2O13.H3O4P/c1-13-36-33(24-57-46-44(56-12)43(55-11)40(53)31(8)59-46)19-25(2)14-15-34(49)28(5)20-32(16-17-48-22-26(3)18-27(4)23-48)42(29(6)35(50)21-37(51)60-36)61-45-41(54)38(47(9)10)39(52)30(7)58-45;1-5(2,3)4/h14-15,19,26-33,35-36,38-46,50,52-54H,13,16-18,20-24H2,1-12H3;(H3,1,2,3,4)/b15-14+,25-19+;/t26-,27+,28-,29+,30-,31-,32+,33-,35-,36-,38+,39-,40-,41-,42-,43-,44-,45+,46-;/m1./s1
    2.1.3 InChI Key
    NESIVXZOSKKUDP-ARVJLQODSA-N
    2.1.4 Canonical SMILES
    CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC.OP(=O)(O)O
    2.1.5 Isomeric SMILES
    CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CCN3C[C@@H](C[C@@H](C3)C)C)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC.OP(=O)(O)O
    2.2 Other Identifiers
    2.2.1 UNII
    SMH7U1S683
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin

    2. El 870

    3. El-870

    4. Micotil 300

    5. Tilmicosin

    2.3.2 Depositor-Supplied Synonyms

    1. 137330-13-3

    2. Tilmicosin (phosphate)

    3. Tilmicosin Phosphate [usan]

    4. Ly177370 Phosphate

    5. Micotil 300

    6. Smh7u1s683

    7. Tilmicosin Phosphate (usan)

    8. (4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4s,5s,6r)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-7-[2-[(3s,5r)-3,5-dimethylpiperidin-1-yl]ethyl]-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione;phosphoric Acid

    9. Tilmicosinphosphate

    10. Pulmotil 90

    11. Unii-smh7u1s683

    12. Tilmicosin Phosphate, Usp

    13. Schembl1184136

    14. Chembl2105782

    15. Hy-b0905a

    16. Ly-177370 Phosphate

    17. Dtxsid201019820

    18. 20-deoxo-20-(3,5-dimethyl-1-piperidinyl)desmycosin Phosphate

    19. Mfcd06797805

    20. S5573

    21. Tilmicosin Phosphate [mart.]

    22. Ccg-270598

    23. Cs-4729

    24. Tilmicosin Phosphate [green Book]

    25. 4a-o-de(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-20-deoxo-20-(cis-3,5-dimethylpiperidino)tylosin Phosphate (1:1) (salt)

    26. Tylosin, 4a-o-de(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-20-deoxo-20-(3,5-dimethyl-1-piperidinyl)-, (20(cis))-, Phosphate (1:1) (salt)

    27. D02493

    28. 330t133

    29. Q-201834

    30. Q27289281

    31. Tilmicosin Phosphate, Antibiotic For Culture Media Use Only

    32. (4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-{[(2r,3r,4s,5s,6r)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-7-{2-[(3r,5s)-3,5-dimethylpiperidin-1-yl]ethyl}-16-ethyl-4-hydroxy-15-({[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione; Phosphoric Acid

    33. 4 Sup(a)-o-de(2,6-dideoxy-3-c-methyl-.alpha.-l-ribo-hexopyranosyl)-20-deoxo-20-(cis-3,5-dimethylpiperidino)tylosin Phosphate (1:1) (salt)

    34. 4(sup A)-o-de(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-20-deoxo-20-(cis-3,5-dimethylpiperidino)tylosin Phosphate (1:1) (salt)

    35. Tylosin, 4 Sup(a)-o-de(2,6-dideoxy-3-c-methyl-.alpha.-l-ribo-hexopyranosyl)-20-deoxo-20-(3,5-dimethyl-1-piperidinyl)-, (20(cis))-, Phosphate (1:1) (salt)

    36. Tylosin, 4(sup A)-o-de(2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)-20-deoxo-20-(3,5-dimethyl-1-piperidinyl)-, (20(cis))-, Phosphate (1:1) (salt)

    2.4 Create Date
    2005-10-11
    3 Chemical and Physical Properties
    Molecular Weight 967.1 g/mol
    Molecular Formula C46H83N2O17P
    Hydrogen Bond Donor Count7
    Hydrogen Bond Acceptor Count19
    Rotatable Bond Count12
    Exact Mass966.54293618 g/mol
    Monoisotopic Mass966.54293618 g/mol
    Topological Polar Surface Area264 Ų
    Heavy Atom Count66
    Formal Charge0
    Complexity1470
    Isotope Atom Count0
    Defined Atom Stereocenter Count19
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count2
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

    Post Enquiry
    POST ENQUIRY